Actionable targets to reduce COVID-19 severity
Nat Metab
.
2023 Feb;5(2):195-196.
doi: 10.1038/s42255-023-00743-9.
Authors
Shiu Lun Au Yeung
1
,
Shan Luo
2
,
Kin On Kwok
3
4
5
Affiliations
1
School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China. ayslryan@hku.hk.
2
School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
3
Jockey Club School of Public Health and Primary Care, Faculty of Medicine, Chinese University of Hong Kong, Hong Kong SAR, China.
4
Stanley Ho Centre for Emerging Infectious Diseases, The Chinese University of Hong Kong, Hong Kong SAR, China.
5
Hong Kong Institute of Asia-Pacific Studies, The Chinese University of Hong Kong, Hong Kong SAR, China.
PMID:
36805565
DOI:
10.1038/s42255-023-00743-9
No abstract available
Publication types
Research Support, Non-U.S. Gov't
Comment
MeSH terms
COVID-19* / therapy
Humans
Patient Acuity*
Grants and funding
200861/Z/16/Z/WT_/Wellcome Trust/United Kingdom